Strategies to Accelerate the Path to Clinic for Next-Generation Antibodies

Join Catalent Biologics for an Exclusive Hosted Webinar and Discussion:

Strategies to Accelerate the Path to Clinic for

Next-Generation Antibodies

AVAILABLE ON-DEMAND

Note: If you have already registered for this webinar, please click this link and use your email to login to the platform again

Event Details:

Some of the latest promising biopharmaceutical developments rely on antibody and antibody fragments that could be engineered for a variety of clinical applications. However, these next-generation antibodies, particularly antibody fragments, possess an increased level of complexity and technical challenges that may result in longer CMC development timelines and delays to clinical trials as well as commercial launch. In this webinar, experts will discuss formulation development and purification strategies to increase throughput, reduce operating costs and potentially decrease development times for monoclonal antibody fragments.

First Name*

Last Name*

Email*

Job Level*

Company*

Country*

Phone

Primary Area of Interest*

Reason for Interest*

Keep Me Informed (Opt In)

Paresh Vadgama

Principal Scientist, Biologics Formulation and Drug Product Development,

Catalent

Jonas Wege

Application Specialist, Separations & Purification,

Tosoh Bioscience

By submitting this form you understand and accept that Catalent tracks your website activities to be able to offer you a more tailored response or information to meet your requirements, and that your personal data will be held in accordance with our Privacy Policy | Privacy Shield Statement.